Infectious Diseases News and Research

RSS

DBS helps anorexia patients achieve and maintain improvements in body weight, mood and anxiety

In a world first, a team of researchers at the Krembil Neuroscience Centre and the University Health Network have shown that Deep Brain Stimulation (DBS) in patients with chronic, severe and treatment-resistant Anorexia Nervosa (anorexia) helps some patients achieve and maintain improvements in body weight, mood, and anxiety.

6 Mar 2013

Lactated Ringer’s safety caution in cardiac arrest

Prehospital intravenous loading with lactated Ringer’s solution may reduce the chances for survival with good neurologic outcome among patients with out-of-hospital cardiac arrest, an observational study suggests.

6 Mar 2013

Case of immigrant with XDR-TB shows global vulnerability to infectious diseases, Wall Street Journal reports

The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries -- from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas -- show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."

6 Mar 2013

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

In Africa and Thailand, communities that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study presented this week at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

6 Mar 2013

European scientists find root cause of age-related dementia

A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.

6 Mar 2013

Increased pneumonia rates after Japan earthquake

Significantly increased rates of pneumonia and related deaths were seen after the 2011 Earthquake and Tsunami in Tohoku, Japan, report researchers.

5 Mar 2013

Discovery provides clues for potentially eliminating HIV infection in children

A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

5 Mar 2013

HIV might promote aging and disease progression in people with HCV, study results suggest

Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus, co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

5 Mar 2013

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham Medical Research Institute and 60- Pharmaceuticals, LLC, have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

Sanford Health announces new limb preservation program

Sanford Health announces a new limb preservation program, Sanford Limb Preservation Center. The center specializes in treating lower extremity wounds in patients at high risk of amputation and compromised leg and toe function, particularly those with diabetes and peripheral arterial disease.

5 Mar 2013

Researchers identify smoking gun for environmental exposures to affect future generations

Grandmother's cigarette smoking could be responsible for her grandchild's asthma, and the recent discovery of this multi-generational transmission of disease suggests the environmental factors experienced today could determine the health of family members for generations to come, two Los Angeles Biomedical Research Institute (LA BioMed) lead researchers write in the March edition of Review of Obstetrics & Gynecology.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Idera Pharmaceuticals, Inc. today announced the presentation of new data showing that its selective Toll-like receptor antagonists, IMO-3100 and IMO-8400, normalized the gene expression of important cytokines in a preclinical study of skin inflammation that is commonly used as a model of psoriasis.

4 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.

1 Mar 2013

Steroids may reduce length of hospital stay in patients with pneumonia

Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients.

1 Mar 2013

Sequester scare touches issues related to Medicare, Medicaid spending

The $85 billion in scheduled spending cuts to defense and discretionary accounts are scheduled to kick in Friday, and movement toward a last-ditch strategy has not been evident.

28 Feb 2013

Infectious Diseases News and Research

DBS helps anorexia patients achieve and maintain improvements in body weight, mood and anxiety

Lactated Ringer’s safety caution in cardiac arrest

Case of immigrant with XDR-TB shows global vulnerability to infectious diseases, Wall Street Journal reports

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

European scientists find root cause of age-related dementia

Increased pneumonia rates after Japan earthquake

Discovery provides clues for potentially eliminating HIV infection in children

HIV might promote aging and disease progression in people with HCV, study results suggest

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Sanford Health announces new limb preservation program

Researchers identify smoking gun for environmental exposures to affect future generations

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Steroids may reduce length of hospital stay in patients with pneumonia

Sequester scare touches issues related to Medicare, Medicaid spending

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News